Synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation

Journal of Cellular Biochemistry

Volumn 67, Issue 4, 1997, Pages 423-431

  Condorelli, Gianluigi ^a,b   Giordano, Antonio ^c,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Sbarro Inst Cancer Res Molec Med   (United States)

Author keywords

Differentiation; DNA tumor viruses; E1A binding proteins

Indexed keywords

BINDING PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADIPOCYTE; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; HEMATOPOIESIS; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY;

ADENOVIRUS E1A PROTEINS; ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELLS; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, RETINOBLASTOMA; HEMATOPOIESIS; HUMANS; MICE; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; RETINOBLASTOMA PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

TUMOR VIRUS;

EID: 0030697508     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971215)67:4<423::AID-JCB1>3.0.CO;2-U     Document Type: Review

References (53)

1. Arany Z, Sellers WR, Livingston DM, Eckner R (1994): E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77(6):799-800.
2. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997): Recruitment of p300/CBP in p53-dependent signal pathways. Cell 1175-1184.
3. Billon N, van Grunsven LA, Rudkin BB (1996): The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13(10):2047-2054.
4. Cardoso MC, Leonhardt H, Nadal-Ginard B (1993): Reversal of terminal differentiation and control of DNA replication: Cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74(6):979-992.
5. Caruso M, Martelli F, Giordano A, Felsani A (1993): Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8(2):267-278.
6. Condorelli G, Vitelli L, Valtieri M, Marta I, Montesoro E, Lulli V, Baer R, Peschle C (1995): Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 86(1):164-175.
7. Condorelli GL, Testa U, Valtieri M, Vitelli L, De Luca A, Barberi T, Montesoro E, Campisi S, Giordano A, Peschle C (1995): Modulation of retinoblastoma gene in normal adult hematopoiesis: Peak expression and functional role in advanced erythroid differentiation. Proc Natl Acad Sci USA 92(11):4808-4812.
8. Coppola JA, Lewis BA, Cole MD (1990): Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5(11):1731-1733.
9. Datto MB, Hu PP, Kowalik TF, Yingling J, Wang XF (1997): The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol Cell Biol 17(4):2030-2037.
10. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A (1997): A unique domain of pRb2/130 acts an inhibitor of cdk2 kinase activity. J Biol Chem. 272:20971-20974.
11. DeCaprio JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston DM (1992): The retinoblastoma-susceptibility gene
12. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (1993): Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72(3):309-324.
13. Gu W, Shi X-L, Roeder RG (1997): Synergistic activation of transcription by CBP and p53. Nature 387:819-823.
14. Guo K, Wang J, Andres V, Smith RC, Walsh K (1995): MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15(7):3823-3829.
15. Guy CT, Zhou W, Kaufman S, Robinson MO (1996): E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol 16(2):685-693.
16. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995): Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267(5200):1018-1021.
17. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E (1996): The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 10(4):461-477.
18. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992): Effects of an Rb mutation in the mouse. Nature 359(6393):295-300.
19. Jacobson MD, Weil M, Raff MC (1997): Programmed cell death in animal development. Cell 88(3):347-354.
20. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996): A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85(3):403-414.
21. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A (1992): Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359(6393):288-294.
22. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T (1996): Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10(13):1621-1632.
23. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM (1997): Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
24. Lundblad JR, Kwok RP, Laurance ME, Harter ML, Goodman RH (1995): Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374(6517):85-88.
25. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T (1995): p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9(8):935-944.
26. Mao S, Neale GA, Goorha RM (1997): T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2. Oncogene 14(13):1531-1539.
27. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP (1995): Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92(12):5451-5455.
28. Morgenbesser SD, Williams BO, Jacks T, DePinho RA (1994): p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371(6492):72-74.
29. Mymryk JS, Lee RW, Baylcy ST (1992): Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol Biol Cell 3(10):1107-1115.
30. Nadal-Ginard B (1978): Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15(3):855-864.
31. Novitch BG, Mulligan GJ, Jacks T, Lassar AB (1996): Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J Cell Biol 135(2):441-456.
32. Paggi MG, Baldi A, Bonetto F, Giordano A (1996): Retinoblastoma protein family in cell cycle and cancer: A review. J. Cell Biochem 62:418-430.
33. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ ( 1995): p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci USA 89:1795-1798.
34. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ (1997): Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275(5299):523-527.
35. Puri PL, Avantaggiati ML, Balsano C, Sang N, Graessmann A, Giordano A, Levrero M (1997): p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. Embo J 16(2):369-383.
36. Qin XQ, Livingston DM, Kaelin WG, Jr, Adams PD (1994): Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91(23):10918-10922.
37. Sartorelli V, Huang J, Hamamori Y, Kedes L (1997): Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 17(2):1010-1026.
38. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990): The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6):1129-1136.
39. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B (1994): Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264(5164):1467-1471.
40. Shan B, Lee WH (1994): Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14(12):8166-8173.
41. Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB (1996): Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol 16(12):7043-7053.
42. Skapek SX, Rhee J, Spicer DB, Lassar AB (1995): Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267(5200):1022-1024
43. Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR (1996): The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol 16(12):6965-6976.
44. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME (1994): Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9(11):3389-3396.
45. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994): Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369(6482):669-671.
46. Webster KA, Muscat GE, Kedes L (1988): Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature 332(6164):553-557.
47. Weinberg RA (1995): The retinoblastoma protein and cell cycle control. Cell 81(3):323-330.
48. Werness BA, Levine AJ, Howley PM (1990): Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248(4951):76-79.
49. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E (1988): Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334(6178):124-129.
50. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T (1994): Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. Embo J 13(18):4251-4259.
51. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ (1996): Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85(4):537-548.
52. Yuan W, Condorelli G, Caruso M, Felsani A, Giordano A (1996): Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem 271(15):9009-9013.
53. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL (1996): pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 10(23):3051-3064.